Andromeda Capital’s Herbalife HLF Stock Holding History

Andromeda Capital’s Portfolio HLF Stock Details HLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-306,800	Closed	-$6.92M	–	83
2013 Q2	$6.92M	Buy	+306,800	New	+$6.53M	0.97%	29

Other funds holding HLF

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RR Partners New York $929M AUM 110.28% 1-Year Est. Return

Perry Capital New York $334M AUM 8.27% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Andromeda Capital's HLF Position: Q3 2013 in Review

Andromeda Capital sold out of Herbalife (HLF) in Q3 2013, closing a stake of 139,188 shares — an estimated $3.14M sold.

Andromeda Capital first reported a position in HLF in Q2 2013 and held it in 1 quarter. The position peaked at $3.14M in Q2 2013. 303 funds tracked by Wall St. Rank hold HLF as of Q3 2013.

Andromeda Capital reported no remaining Herbalife position as of Q3 2013 after selling out during the quarter.
Andromeda Capital sold 139,188 Herbalife shares in Q3 2013, an estimated $3.14M.
Andromeda Capital first reported a position in Herbalife in Q2 2013 and held it in 1 quarter.
Andromeda Capital's Herbalife position peaked at $3.14M in Q2 2013.
303 funds tracked by Wall St. Rank held Herbalife as of Q3 2013.

Based on Andromeda Capital's 13F filing for Q3 2013, filed 14 Nov 2013.